CJC-1295 with DAC – Long-Acting GHRH Analogue Research Peptide
CJC-1295 with DAC is a synthetic Growth Hormone–Releasing Hormone (GHRH) analogue
that has been modified with a Drug Affinity Complex (DAC) to significantly extend its
half-life. In laboratory research, this peptide is used to study the
prolonged stimulation of growth hormone (GH) and IGF-1 secretion
via the GHRH receptor under in-vitro conditions.
CJC-1295 with DAC is manufactured according to high laboratory standards and verified using
High-Performance Liquid Chromatography (HPLC) to ensure a purity of
≥ 99%. Each batch is supplied exclusively for controlled
endocrinological and biochemical research applications.
Key specifications
| Specification | Value / description |
|---|---|
| Name | CJC-1295 with DAC (Drug Affinity Complex) |
| Molecular formula | C165H271N47O46 |
| Molecular weight | ≈ 3647.1 Da |
| Form | Lyophilized powder |
| Purity | ≥ 99% (HPLC tested) |
| Storage conditions | Store refrigerated, protected from light and moisture |
Application & use (research only)
- Intended exclusively for in-vitro research purposes.
- Not suitable for human or veterinary consumption or medical use.
- Applicable to endocrinological and biochemical research on growth hormone release and receptor activity.
- Lyophilized form supports stable storage and controlled laboratory handling.
